000151626 001__ 151626
000151626 005__ 20240618100615.0
000151626 0247_ $$2doi$$a10.1016/S1474-4422(19)30368-0
000151626 0247_ $$2pmid$$apmid:31958406
000151626 0247_ $$2pmc$$apmc:PMC7062546
000151626 0247_ $$2ISSN$$a1474-4422
000151626 0247_ $$2ISSN$$a1474-4465
000151626 0247_ $$2altmetric$$aaltmetric:74168938
000151626 037__ $$aDZNE-2020-01208
000151626 041__ $$aEnglish
000151626 082__ $$a610
000151626 1001_ $$0P:(DE-2719)2000032$$aJessen, Frank$$b0$$eFirst author$$udzne
000151626 245__ $$aThe characterisation of subjective cognitive decline.
000151626 260__ $$aLondon$$bLancet Publ. Group$$c2020
000151626 3367_ $$2DRIVER$$aarticle
000151626 3367_ $$2DataCite$$aOutput Types/Journal article
000151626 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1718697926_13423
000151626 3367_ $$2BibTeX$$aARTICLE
000151626 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000151626 3367_ $$00$$2EndNote$$aJournal Article
000151626 520__ $$aA growing awareness about brain health and Alzheimer's disease in the general population is leading to an increasing number of cognitively unimpaired individuals, who are concerned that they have reduced cognitive function, to approach the medical system for help. The term subjective cognitive decline (SCD) was conceived in 2014 to describe this condition. Epidemiological data provide evidence that the risk for mild cognitive impairment and dementia is increased in individuals with SCD. However, the majority of individuals with SCD will not show progressive cognitive decline. An individually tailored diagnostic process might be reasonable to identify or exclude underlying medical conditions in an individual with SCD who actively seeks medical help. An increasing number of studies are investigating the link between SCD and the very early stages of Alzheimer's disease and other neurodegenerative diseases.
000151626 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x0
000151626 588__ $$aDataset connected to CrossRef, PubMed,
000151626 650_2 $$2MeSH$$aAlzheimer Disease: diagnosis
000151626 650_2 $$2MeSH$$aAlzheimer Disease: epidemiology
000151626 650_2 $$2MeSH$$aBrain
000151626 650_2 $$2MeSH$$aCognition: physiology
000151626 650_2 $$2MeSH$$aCognitive Dysfunction: diagnosis
000151626 650_2 $$2MeSH$$aDiagnostic Self Evaluation
000151626 650_2 $$2MeSH$$aDisease Progression
000151626 650_2 $$2MeSH$$aHumans
000151626 650_2 $$2MeSH$$aNeuropsychological Tests
000151626 693__ $$0EXP:(DE-2719)DELCODE-20140101$$5EXP:(DE-2719)DELCODE-20140101$$eLongitudinal Cognitive Impairment and Dementia Study$$x0
000151626 7001_ $$aAmariglio, Rebecca E$$b1
000151626 7001_ $$aBuckley, Rachel F$$b2
000151626 7001_ $$avan der Flier, Wiesje M$$b3
000151626 7001_ $$aHan, Ying$$b4
000151626 7001_ $$aMolinuevo, José Luis$$b5
000151626 7001_ $$aRabin, Laura$$b6
000151626 7001_ $$aRentz, Dorene M$$b7
000151626 7001_ $$aRodriguez-Gomez, Octavio$$b8
000151626 7001_ $$aSaykin, Andrew J$$b9
000151626 7001_ $$aSikkes, Sietske A M$$b10
000151626 7001_ $$aSmart, Colette M$$b11
000151626 7001_ $$0P:(DE-2719)2810544$$aWolfsgruber, Steffen$$b12$$udzne
000151626 7001_ $$0P:(DE-2719)2000057$$aWagner, Michael$$b13$$eLast author$$udzne
000151626 773__ $$0PERI:(DE-600)2079704-7$$a10.1016/S1474-4422(19)30368-0$$gVol. 19, no. 3, p. 271 - 278$$n3$$p271 - 278$$tThe lancet <London> / Neurology$$v19$$x1474-4422$$y2020
000151626 8564_ $$uhttps://pub.dzne.de/record/151626/files/DZNE-2020-01208_Restricted.pdf
000151626 8564_ $$uhttps://pub.dzne.de/record/151626/files/DZNE-2020-01208_Restricted.pdf?subformat=pdfa$$xpdfa
000151626 909CO $$ooai:pub.dzne.de:151626$$pVDB
000151626 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000032$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000151626 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810544$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b12$$kDZNE
000151626 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000057$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b13$$kDZNE
000151626 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x0
000151626 9141_ $$y2020
000151626 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-02-27
000151626 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-09
000151626 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-09
000151626 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-09
000151626 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-09
000151626 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLANCET NEUROL : 2021$$d2022-11-09
000151626 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-09
000151626 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-09
000151626 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-09
000151626 915__ $$0StatID:(DE-HGF)9950$$2StatID$$aIF >= 50$$bLANCET NEUROL : 2021$$d2022-11-09
000151626 9201_ $$0I:(DE-2719)1011102$$kAG Jessen$$lClinical Alzheimer’s Disease Research$$x0
000151626 9201_ $$0I:(DE-2719)1011201$$kAG Wagner$$lNeuropsychology$$x1
000151626 9201_ $$0I:(DE-2719)5000034$$kDelcode$$lDelcode$$x2
000151626 980__ $$ajournal
000151626 980__ $$aVDB
000151626 980__ $$aI:(DE-2719)1011102
000151626 980__ $$aI:(DE-2719)1011201
000151626 980__ $$aI:(DE-2719)5000034
000151626 980__ $$aUNRESTRICTED